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ABSTRACT 26 
Resistance to MLSB in Clostridium difficile is generally due to erm(B) genes. Tn6194, a 27 
conjugative transposon initially detected in PCR-ribotype 027 isolates is an erm(B)-28 
containing element also detected in other relevant Clostridium difficile PCR-ribotypes. In 29 
this study, the genome of a C. difficile PCR-ribotype 001 strain was sequenced and an 30 
element with two nucleotidic changes compared to Tn6194 was detected. This element 31 
was transferred by filter-mating assays to recipient strains of C. difficile belonging to PCR-32 
ribotype 009 and 027, and to a recipient strain of Enterococcus faecalis. Transconjugants 33 
were characterised by Southern blotting and genome sequencing, and integration sites in 34 
all transconjugants were identified by sspPCR. The element integrated the genome of C. 35 
difficile at different sites and the genome of E. faecalis at a unique site. This study is the 36 
first molecular characterisation of a erm(B)-containing conjugative transposon in C. 37 
difficile, and provide an additional evidence of the antibiotic resistance’s transmission risk 38 
between pathogenic bacteria occupying the same human intestinal niche.39 
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INTRODUCTION 40 
Resistance to the macrolide-lincosamide-streptogramin B (MLSB) group of antibiotics is the 41 
most common phenotype in clinical isolates of C. difficile worldwide, and is generally 42 
conferred by erm(B) genes encoding 23S rRNA methylases (Huang et al., 2009). These 43 
genes are located on mobile elements showing an important heterogeneity in their genetic 44 
organisation (Farrow et al., 2001; Spigaglia et al., 2005; Spigaglia et al., 2011). The best 45 
known of them is Tn5398 from C. difficile 630, a mobilizable non-conjugative element 46 
containing two erm(B) copies (Farrow et al., 2001).  47 
A putative conjugative transposon belonging to the Tn916-like family of transposons and 48 
carrying an erm(B) gene has been recently detected in C. difficile 2007855, a strain 49 
belonging to the hyper-virulent PCR-ribotype 027, and designated Tn6194 (He et al., 50 
2010; He et al., 2012). Conjugative transposons related to Tn916 were originally detected 51 
in Enterococcus faecalis, which inhabits the same niche of C. difficile. Both species are 52 
responsible for nosocomial infections, and horizontal gene transfer between those two 53 
species has been previously proven (Jasni et al., 2010). 54 
A recent whole-genome sequencing analysis of C. difficile 027/BI/NAP1 isolates 55 
demonstrated that Tn6194 was present in most of the strains belonging to the FQR1 56 
lineage, isolated in the United States and in Asia (He et al., 2012). Moreover, recent 57 
studies showed that this transposon is the most frequently found erm(B)-containing 58 
element in different epidemic PCR-ribotypes circulating in European hospitals (Spigaglia et 59 
al., 2011; Wasels et al., 2013), and a transposon almost identical has been detected in the 60 
PCR-ribotype 017 strain M68 genome (Brouwer et al., 2012).. 61 
In this study, we characterized the element of a C. difficile PCR-ribotype 001 clinical 62 
isolate and we investigated its intra and inter-species transfer capacities by transferring it 63 
to recipient strains of C. difficile and E. faecalis. 64 
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MATERIALS AND METHODS 65 
Bacterial strains, culture conditions and antibiotic susceptibility 66 
All strains used in this study, listed in Table 1, were grown on Brain Heart Infusion (BHI) 67 
agar plates or in BHI broth (Oxoid Ltd, Basingstoke, UK) supplemented with 0.5% yeast 68 
extract and 0.1% L-cysteine (BHIS). C. difficile was grown at 35°C in anaerobic conditions 69 
(85% N2, 10% H2, 5% CO2) and E. faecalis at 37°C in aerobic conditions. Erythromycin 70 
and rifampicin were used at a final concentration of 20 mg/L.  71 
Minimal Inhibitory Concentrations (MICs) were determined using the Etest (AB Biodisk, 72 
Solna, Sweden) as already described. The breakpoint used for both erythromycin and 73 
clindamycin was 8 mg/L, in accordance with the guidelines established by the Clinical and 74 
Laboratory Standards Institute (CLSI, 2007). The breakpoint for rifampicin was 4 mg/L, in 75 
accordance with the CLSI interpretive categories approved for Staphylococcus aureus, 76 
since no values are provided for anaerobes (CLSI, 2008). 77 
 78 
Filter-mating assays 79 
Filter-mating experiments were performed as already described (Farrow et al., 2001). C. 80 
difficile transconjugants were selected anaerobically on plates supplemented with 81 
erythromycin and rifampicin, and were confirmed by PCR-ribotyping as already described 82 
(Bidet et al., 2009) and PCR detection of erm(B) using primers E5 and E6 (Spigaglia & 83 
Mastrantonio, 2004). E. faecalis transconjugants were selected aerobically on plates 84 
supplemented with erythromycin, and confirmed by PCR detection of erm(B). 85 
 86 
Genomic DNA extraction 87 
Genomic DNA extractions were performed using the NucleoBond® AXG columns and 88 
NucleoBond® Buffer Set III (Macherey-Nagel) according to the manufacturer’s 89 
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instructions, with the following modifications: double volume of lysozyme and proteinase K 90 
were used during the cell disruption step and incubation time at 37°C was tripled. 91 
 92 
Analysis of C. difficile CII7 transposon insertion sites 93 
Southern blotting was carried out by transferring 3 µg of HindIII-digested genomic DNA 94 
from C. difficile strains to a Hybond™ N+ membrane (Amersham Biosciences, 95 
Buckinghamshire, UK). The erm(B)-specific probe was obtained by PCR using primers E5 96 
and E6. Hybridisation and signal detection were carried out as described in the ECL™ 97 
Direct Nucleic Acid Labelling and Detection System (Amersham Biosciences). 98 
SspPCR were performed using primers listed in the Supplementary Table 1 on fragments 99 
of genomic DNA digested by HindIII, Sau3AI or NdeI genomic fragments ligated within the 100 
dephosphorylated pUC19 digested with HindIII, BamHI or NdeI. Primers used to confirm 101 
insertion sites by PCR are listed in the Supplementary Table 2. 102 
 103 
Genome sequencing 104 
Single-end multiplex libraries were created with multiplexed protocol according to the 105 
manufacturer’s specification; the sequencing was performed on the Illumina HiSeq 2000 106 
platform. The read length was 110-bp for both C. difficile CII7 and C. difficile 107 
CII7xCD37(A). Then reads were assembled de novo into contigs using Velvet (Zerbino & 108 
Birney, 2008) (Options: Kmer : 71 and 75 respectively for CII7 and CII7xCD37(A) ; –short ; 109 
–fastq ; –unused_reads ; -read_trkg). Finally contigs (minimum size, 500 bases) were 110 
reorganized and oriented based on alignment to the finished genome of C. difficile strain 111 
630 (CD630) (Sebaihia et al., 2006). Contigs that did not match CD630 were localized at 112 
the end to obtain each genome scaffold. The short reads genomic data have been 113 
deposited in the European Nucleotide Archive (ENA) under accession number 114 
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‘PRJEB1488’ and can be accessed online (http://www.ebi.ac.uk/ena/data/view/ 115 
PRJEB1488). 116 
The nucleotide sequence of the Tn6194-like element from C. difficile CII7 has been 117 
deposited in the ENA database (http://www.ebi.ac.uk/ena/) under accession no. 118 
HG475346.119 
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RESULTS 120 
The entire genome of the PCR-ribotype 001 C. difficile strain CII7 that has been previously 121 
shown to contain an element highly similar to Tn6194 was sequenced, and a putative 122 
conjugative transposon of 28014 bp in length with two nucleotide changes compared to 123 
Tn6194 was detected (Fig. 1). Insertion of a guanine at position 7076 (between positions 124 
3152104 and 3152105 in C. difficile 2007855; GenBank accession number FN665654) 125 
determines a 207nt-elongation of the CDS coding for a replication initiation factor 126 
homologous to orf20 of Tn916. The same insertion is also present in the transposon from 127 
the C. difficile M68 strain (GenBank accession number FN668375). The replacement of a 128 
guanine by a thymine at position 9691 (positions 3149490 in C. difficile 2007855) causes 129 
the substitution of a methionine by an isoleucine within the sequence of a protein with 130 
unknown function. The transposon is located between orthologs of C. difficile 630 131 
CD630_31060 and CD630_31070 in C. difficile CII7, while it is integrated within the coding 132 
sequences of the ortholog of CD630_28310 and CD630_33170 in strains 2007855 and 133 
M68, respectively.  134 
 135 
Filter-mating assays were carried out to transfer the transposon from CII7 to C. difficile 136 
CD37 (MICs = 0.75 mg/L for erythromycin and 3.0 mg/L for clindamycin) and to CD196R, 137 
a rifampicin-resistant derivative of C. difficile CD196 (MICs = 1.0 mg/L for erythromycin 138 
and 2.0 mg/L for clindamycin). In this study, transfer was achieved at a frequency of 1.01 ± 139 
0.36 x 10-8 and 1.43 ± 0.87 x 10-8 per donor for CD37 and CD196R, respectively. 140 
Transconjugants were selected from independent experiments to exclude the possibility of 141 
analysing siblings. Filter-mating assays were also performed using C. difficile CII7 or each 142 
one of the four transconjugants CII7xCD37 as donor, and the MLSB-susceptible E. faecalis 143 
JH2-2 strain as recipient (MICs = 0.38 mg/L for erythromycin and 8.0 mg/L for 144 
clindamycin). Transfer was achieved at a frequency of 1.74 ± 1.91 10-6 per donor. Two 145 
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independent transconjugants were obtained from each transfer, for a total of 10 E. faecalis 146 
transconjugants. All transconjugants obtained were highly resistant to both erythromycin 147 
and clindamycin (MIC ≥ 256 mg/L), as the donor strain C. difficile CII7 was. 148 
 149 
Southern blot analysis showed that the conjugative transposon from CII7 integrated the 150 
genome of C. difficile CD37 and CD196 at different sites, whereas a unique insertion site 151 
in the genome of E. faecalis JH2-2 was observed (Fig. 2). 152 
The genome of the transconjugant CII7xCD37a was completely sequenced and compared 153 
to that of CD37 (GenBank accession number AHJJ01). The transposon was detected 154 
within a copy of the 23S rRNA gene, and no other genetic material from strain CII7 was 155 
detected in CII7xCD37a. The integration site of the element was also determined in all 156 
transconjugants by sspPCR and confirmed by subsequent PCR and Sanger sequencing. 157 
In total, seven different insertion sites were detected in the eight C. difficile 158 
transconjugants examined, whereas a unique insertion site was identified in the ten E. 159 
faecalis transconjugants analysed. All target sites of the element contained a central AG 160 
dinucleotide (Table 2). 161 
Integration within a copy of the 23S rRNA gene was confirmed in CII7xCD37a and the 162 
transposon was also found in a copy of this gene in CII7xCD196Rd, although at a different 163 
site. In CII7xCD37d the transposon was located between orthologs of C. difficile 630 164 
CD630_31060 and CD630_31070, like in the donor C. difficile CII7, whereas in 165 
CII7xCD196Rc it was detected within the coding sequences of the ortholog of 166 
CD630_28310, like in C. difficile 2007855. Finally, the transposon was integrated at the 167 
same position within a copy of the tRNAArg gene in transconjugants CII7xCD37c and 168 
CII7xCD196Rb. In all E. faecalis transconjugants, the transposon was always located 169 
within a copy of the tRNAArg gene. Although no genomic data were available about strain 170 
JH2-2, it can be hypothesised that, like E. faecalis V583 and OG1RF (Genbank accession 171 
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number NC_004668 and CP002621, respectively), its genome contains several copies of 172 
the tRNAArg gene. Interestingly, the element always integrated the same locus (Fig. 2). In 173 
CII7 and in all transconjugants obtained in this study, the transposon was able to excise 174 
from the genome and form a circular intermediate, restoring the original target site (data 175 
not shown). 176 
177 
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DISCUSSION 178 
Tn6194 is an erm(B)-containing conjugative transposon recently detected in strains 179 
belonging to different PCR-ribotypes, worldwide (He et al., 2010; Spigaglia et al., 2011; He 180 
et al., 2012; Wasels et al., 2013). In this study, the capacity of this element to be 181 
transferred to other strains of C. difficile as well as to E. faecalis was investigated. While 182 
the conjugative transposon Tn5397 from C. difficile 630, which confer resistance to 183 
tetracycline, has been successfully transferred to E. faecalis JH2-2 (Jasni et al., 2010), this 184 
is the first evidence of transfer of MLSB resistance between these two species, at our 185 
knowledge. 186 
There are clear differences of behaviour between conjugative transposons, most likely due 187 
to their respective recombination modules and to the recipient strain used. While Tn916 188 
has a highly preferred insertion site in C. difficile CD37, it can integrate the genome of C. 189 
difficile 630∆erm and R20291 or E. faecalis JH2-2 at different sites (Mullany et al., 2012; 190 
Wang et al., 2000). Differently, Tn5397, which contains the tndX gene encoding a serine 191 
recombinase, has a preferred integration site in C. difficile CD37, two in C. difficile 192 
R20291, one in E. faecalis JH2-2 and enters the genome of Bacillus subtilis CU2189 at 193 
different sites (Jasni et al., 2010; Mullany et al., 1990). Like Tn916, Tn6194 contains 194 
genes encoding for putative tyrosine integrase and excisionase (Brouwer et al., 2012). Our 195 
results suggest that there are a limited number of integration sites of this transposon within 196 
the genome of C. difficile CD37 and CD196, and a highly preferential integration site in E. 197 
faecalis JH2-2. 198 
Elements containing erm(B) genes show an important heterogeneity in their genetic 199 
structure. Although it has been extensively studied, Tn5398 from C. difficile 630 has been 200 
mainly detected in PCR-ribotype 012 isolates. Unlike this mobilizable non-conjugative 201 
element, Tn6194 contains all modules required for its transfer between cells. These 202 
characteristics may explain its diffusion among most of the clinically relevant PCR-203 
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ribotypes, underlining the importance of mobile genetic elements in the spread of 204 
resistance in the C. difficile population.205 
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Table 1. Bacterial strains used in this study. 319 
Strain 
a 
Characteristics 
b 
PCR-ribotype Source (Reference) 
C. difficile    
CII7 Ery
R
 Cli
R 
Rif
S 
001 (Barbut 2007) 
CD37 Ery
S 
Cli
S
 Rif
R 
009 (Smith 1981) 
CD196 Ery
S 
Cli
S
 Rif
S 
027 (Popoff 1988) 
CD196R Ery
S 
Cli
S
 Rif
R  
027 this study 
CII7xCD37 a, b, c, d (4) Ery
R 
Cli
R
 Rif
R 
009 this study 
CII7xCD196R a, b, c, d (4) Ery
R 
Cli
R
 Rif
R 
027 this study 
E. faecalis    
JH2-2 Ery
S 
Cli
S
 Rif
R 
 (Jacob 1974) 
CII7xJH2-2 a, b (2) Ery
R 
Cli
R
 Rif
R 
 this study 
[CII7xCD37 A/B/C/D]xJH2-2 a, b (8) Ery
R 
Cli
R
 Rif
R 
 this study 
a
in brackets, number of replicates 
b
Ery
S
: erythromycin susceptible; Ery
R
: erythromycin resistant; Cli
S
: clindamycin susceptible; Cli
R
: clindamycin 
resistant Rif
S
: rifampicin susceptible; Rif
R
: rifampicin resistant. 
 320 
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Table 2. Insertion sites of the Tn6194 and Tn6194-like elements in wild-type strains and transconjugants analysed in this study 321 
 
Strains 
 
 
Transposon localisation 
a 
 
Insertion site 
 
C. difficile 
     
2007855  putative adhesin CDS (CD630_28310) TGTATCTTATGCTTCAGAATTAGG AG AGAATAGTCAGATTCAAAGTGGTT 
M68  fdhF (CD630_33170) TTCATCATCTTCAACTTCCATAGG AG GTCTCCATTCAGCAGCGAACAAGT 
CII7  5'UTR of a transcriptional antiterminator (CD630_31070) AATAAATAGTAACTAAGATTTAGG AG GGTTTGCATTGAACAAAAGATTAT 
Transconjugants     
CII7xCD37 a 23S rRNA gene GAGGAGAGTATCCTAAGGCCAGCG AG AGAACTGTTGTTAAGGAACTCGGC 
b 5'UTR of hfQ (CD630_19740) TTAGAAGTTCAATTTAATCTTGGG AG GGTACAAATCTAATGAAAAATACA 
c tRNA
Arg
 gene CGAACCCCGGACACACGCCTTAGA AG GGCGTTGCTCTATCCAGCTGAGCT 
d 5'UTR of a transcriptional antiterminator (CD630_31070) AATAAATAGTAACTAAGATTTAGG AG GGTTTGCATTGAACAAAAGATTAT 
CII7xCD196R a eutL (CD630_19150) TTGACGAAGCAACTAAAGCTTCAG AG GTTGATGTTGTATATGCAAAATCA 
b tRNA
Arg
 gene CGAACCCCGGACACACGCCTTAGA AG GGCGTTGCTCTATCCAGCTGAGCT 
c putative adhesin CDS (CD630_28310) TGTATCTTATGCTTCAGAATTAGG AG AGAATAGTCAGATTCAAAGTGGTT 
d 23S rRNA gene GGGAAAGGTGAAAAGAACCCCGGG AG GGGAGTGAAATAGAACCTGAAACC 
E. faecalis      
All transconjugants tRNA
Arg
 gene TGAACCAGCGACCTACCGCTTAGG AG GCGGTTGCTCTATCCTACTGAGCT 
 
a
 orthologous CDS in C. difficile 630 are indicated in brackets. 
  
Figure 1: Tn6194-like element from C. difficile CII7.  
Grey boxes show homology with Tn916 from E. faecalis DS16 and Tn5398 from C. difficile 
630. Genes involved in conjugation and in recombination are shown in dark grey and 
black, respectively. Genes involved in regulation, accessory or still unknown functions are 
in white. 
  
Figure 2: Southern blot analysis of the transconjugants obtained in this study. 
Detection of erm(B) on HindIII-digested genomic DNA of donor, recipient and 
transconjugants obtained after transfer of the transposon from C. difficile CII7 to (A) C. 
difficile CD37, (B) C. difficile CD196 and (C) E. faecalis JH2-2. M: marker (DNA Molecular 
Weight Marker II, Roche). (A) Lane 1: C. difficile CII7; lane 2: C. difficile CD37; lane 3-6: 
transconjugants CII7xCD37 a, b, c and d, respectively. (B) Lane 1: C. difficile CII7; lane 2: 
C. difficile CD196R; lane 3-6: transconjugants CII7xCD196R a, b, c and d, respectively. 
(C) Lane 1: C. difficile CII7; lane 2: E. faecalis JH2-2; lane 3-4, 5-6, 7-8, 9-10 and 11-12: 
transconjugants CII7xJH2-2, (CII7xCD37a)xJH2-2, (CII7xCD37b)xJH2-2, 
(CII7xCD37c)xJH2-2 and (CII7xCD37d)xJH2-2, respectively. 
